Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Therapeutic plasma exchange: applications in neurology].
Exercise in the management of persons with multiple sclerosis.
The Combined Structural and Kinetic Characterization of a Bacterial Nitronate Monooxygenase from Pseudomonas aeruginosa PAO1 Establishes NMO Class I and II.
Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Yes.
Specialized housing and transportation needs of adults with multiple sclerosis.
Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis.
Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment.
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.
Multiple sclerosis or multiple possibilities: The continuing problem of misdiagnosis.
Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS).
A subject-specific framework for in vivo myeloarchitectonic analysis using high resolution quantitative MRI.
Functional organization of an Mbp enhancer exposes striking transcriptional regulatory diversity within myelinating glia.
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
Male rats develop more severe experimental autoimmune encephalomyelitis than female rats: Sexual dimorphism and diergism at the spinal cord level.
Goal attainment in cognitive rehabilitation in MS patients.
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis-Reply.
The effectiveness of fingolimod in a Portuguese real-world population.
Autobiographical memory in multiple sclerosis patients: Assessment and cognitive facilitation.
Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies.
Discovery of novel disease-specific and membrane-associated markers in a mouse model of multiple sclerosis.
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis.
Age-Dependent Decline of Nogo-A Protein in the Mouse Cerebrum.
Pages
« first
‹ previous
…
376
377
378
379
380
381
382
383
384
…
next ›
last »